FIND appoints new Chairman to its Board of Directors

Geneva, Switzerland – 3 April 2013 – FIND announced today the appointment of Mark Kessel to Chairman of its Board of Directors. He was appointed Vice-Chairman last year.

Mark Kessel co-founded Symphony Capital LLC, a private equity firm investing in the clinical development programs of biopharmaceutical companies, in 2002. He is widely recognized as the leader in structuring product development investments for the biopharmaceutical industry. Mr. Kessel was formerly the managing partner of Shearman & Sterling, with day-to-day operating responsibility for one of the largest international law firms. He received a bachelor’s degree with honors in economics from the City College of New York, and a Juris Doctor magna cum laude from Syracuse University College of Law. Mr. Kessel is currently of counsel to Shearman & Sterling, and a director of Dynavax Technologies Corp., FIND and Fondation Santé. He also served as a director of the Biotechnology Industry Organization, the Global Alliance for TB Drug Development, OXiGENE Corp., Antigenics Inc., Heller Financial Inc. and Harrods (UK) Limited and as a trustee of the Museum of the City of New York.

Mr. Kessel has written on financing for the biotech industry for Nature Reviews Drug Discovery, Nature Biotechnology, The Scientist and other publications, and on issues related to governance and audit committees for such publications as The Wall Street Journal, Financial Times, The Deal and Euromoney.

“I would like to thank Dr Möller for paving the way with his dedicated support to FIND and its mission since the organization was created ten years ago,” said Mr. Kessel. “I look forward to our continued collaboration and to supporting FIND in the development and roll-out of ASSURED tests (affordable, sensitive, specific, user-friendly, robust and rapid, equipment-free, and deliverable) for resource-limited settings.”